Dimensional Fund Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.1M | Sell |
540,053
-2,463
| -0.5% | -$79.6K | ﹤0.01% | 2016 |
|
|
2026
Q1 | $17.7M | Buy |
542,516
+82,941
| +18% | +$2.67M | ﹤0.01% | 2030 |
|
|
2025
Q4 | $16.2M | Sell |
459,575
-11,684
| -2% | -$414K | ﹤0.01% | 2084 |
|
|
2025
Q3 | $12.4M | Buy |
471,259
+235,189
| +100% | +$7.02M | ﹤0.01% | 2222 |
|
|
2025
Q2 | $6.26M | Buy |
+236,070
| New | +$6.21M | ﹤0.01% | 2453 |
|
|
2025
Q1 | – | Sell |
-100,762
| Closed | -$4.05M | – | 3357 |
|
|
2024
Q4 | $4.05M | Sell |
100,762
-10,394
| -9% | -$593K | ﹤0.01% | 2596 |
|
|
2024
Q3 | $7.04M | Buy |
111,156
+64,266
| +137% | +$3.77M | ﹤0.01% | 2415 |
|
|
2024
Q2 | $2.49M | Sell |
46,890
-262
| -0.6% | -$17.2K | ﹤0.01% | 2712 |
|
|
2024
Q1 | $3.87M | Sell |
47,152
-14,981
| -24% | -$667K | ﹤0.01% | 2609 |
|
|
2023
Q4 | $1.16M | Sell |
62,133
-364,631
| -85% | -$4.77M | ﹤0.01% | 2902 |
|
|
2023
Q3 | $4.73M | Sell |
426,764
-107,568
| -20% | -$1.54M | ﹤0.01% | 2548 |
|
|
2023
Q2 | $8.66M | Hold |
534,332
| – | – | ﹤0.01% | 2321 |
|
|
2023
Q1 | $8.9M | Sell |
534,332
-314,395
| -37% | -$3.25M | ﹤0.01% | 2281 |
|
|
2022
Q4 | $7.98K | Sell |
848,727
-65,236
| -7% | -$291K | ﹤0.01% | 2296 |
|
|
2022
Q3 | $2.49M | Sell |
913,963
-369,962
| -29% | -$1.21M | ﹤0.01% | 2647 |
|
|
2022
Q2 | $3.71M | Sell |
1,283,925
-91,560
| -7% | -$227K | ﹤0.01% | 2540 |
|
|
2022
Q1 | $4.13M | Buy |
1,375,485
+312,377
| +29% | +$1.12M | ﹤0.01% | 2595 |
|
|
2021
Q4 | $4.89M | Buy |
1,063,108
+296,385
| +39% | +$1.66M | ﹤0.01% | 2572 |
|
|
2021
Q3 | $4.82M | Buy |
766,723
+430,845
| +128% | +$2.66M | ﹤0.01% | 2600 |
|
|
2021
Q2 | $2.01M | Buy |
335,878
+23,474
| +8% | +$139K | ﹤0.01% | 2866 |
|
|
2021
Q1 | $1.98M | Buy |
312,404
+114,045
| +57% | +$802K | ﹤0.01% | 2860 |
|
|
2020
Q4 | $1.12M | Sell |
198,359
-1,466
| -0.7% | -$8.88K | ﹤0.01% | 2957 |
|
|
2020
Q3 | $1.16M | Buy |
199,825
+7,452
| +4% | +$51.3K | ﹤0.01% | 2897 |
|
|
2020
Q2 | $1.39M | Buy |
192,373
+106,046
| +123% | +$704K | ﹤0.01% | 2854 |
|
|
2020
Q1 | $404K | Buy |
86,327
+47,021
| +120% | +$289K | ﹤0.01% | 3093 |
|
|
2019
Q4 | $315K | Buy |
+39,306
| New | +$287K | ﹤0.01% | 3201 |
|
|
2019
Q3 | – | Sell |
-212,048
| Closed | -$1.76M | – | 3437 |
|
|
2019
Q2 | $1.76M | Hold |
212,048
| – | – | ﹤0.01% | 2931 |
|
|
2019
Q1 | $2.11M | Buy |
212,048
+18,800
| +10% | +$157K | ﹤0.01% | 2883 |
|
|
2018
Q4 | $1.48M | Buy |
+193,248
| New | +$2.31M | ﹤0.01% | 2936 |
|
Other funds holding VKTX
Dimensional Fund Advisors's VKTX Position: Q2 2026 in Review
Dimensional Fund Advisors reduced its Viking Therapeutics (VKTX) stake by 0.45% in Q2 2026, selling an estimated $79.6K and leaving 540,053 shares worth $21.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2016.
Dimensional Fund Advisors first reported a position in VKTX in Q4 2018 and has held it in 29 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- Dimensional Fund Advisors held 540,053 shares of Viking Therapeutics worth $21.1M as of Q2 2026.
- Dimensional Fund Advisors sold 2,463 Viking Therapeutics shares in Q2 2026, an estimated $79.6K.
- Viking Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2016 holding.
- Dimensional Fund Advisors first reported a position in Viking Therapeutics in Q4 2018 and has held it in 29 quarters since.
- 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.